ECM Weekly (15th July 2024) - Kokusai, Wiwynn, Kelun-Biotech, Timee, Shift Up, Sanil, Avanse
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
499 Views
EQD / NSE Vol Update / Vega Was Bid & Gamma Was Offered
IVs rise as additional risk premia gets baked in for Budget Announcement. Kinked-shaped term structure with Monthly IVs trading at a markup to rest...
387 Views
Avanse Financial Services Pre-IPO - The Negatives - Immigration Issues
Avanse Financial Services is looking to raise up to US$419m in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of...
467 Views
Avanse Financial Services Pre-IPO - The Positives - Fast Growth in an Expanding Industry
Avanse Financial Services is looking to raise up to US$419m in its upcoming India IPO. In this note, we talk about the positive aspects of the deal.
372 Views
Emcure Pharma Pre-IPO Trading - Strong Subscription, Will Pop
Emcure Pharmaceuticals raised around US$240m in its India IPO. Subscription rates were strong for institutional and HNI tranche.
362 Views